<DOC>
	<DOCNO>NCT02797743</DOCNO>
	<brief_summary>This study obtain whole blood specimen healthy subject use research development clinical validation genetic assay .</brief_summary>
	<brief_title>Whole Blood Specimen Collection From Healthy Subjects</brief_title>
	<detailed_description>Progenity develop diagnostic product improve healthcare men , woman , child . The commercial objective make safe , noninvasive genetic test available public , independent age factor may contribute pregnancy clinical complication . Sample specimen use develop genetic line and/or DNA bank clone . Any sample remnant specimen remain may store indefinitely future research program . Eligible subject ( parent/guardian ) provide write informed consent basic demographic clinical data obtain whole blood sample collect . A subject 's participation may end immediately blood draw . The amount whole blood drawn visit base upon age subject test performed . In event Subject pregnant , information regard gender fetus establish either ultrasound , non-invasive prenatal testing ( NIPT ) result , delivery collect . Clinical data regard karyotyping procedure may occur fetus record .</detailed_description>
	<criteria>Subject ( guardian ) willing provide write informed consent 50 mL whole blood collect single clinic visit ( maximum blood volume depend age subject ) Subject consider healthy ( pregnant , pregnancy progress normally ) If pregnant , Subject carry singleton fetus 10 26 week ' gestational age inclusive Women pregnant If pregnant , pregnancy nonviable If pregnant , evidence suspect fetal anomaly base ultrasound find , abnormal 1st trimester screen abnormal NIPT Immediate family history previous fetal aneuploidy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>